May 11, 2016:
Abstract: Clinical Validation of a live-cell phenotypic biomarker – based diagnostic assay for the prediction of adverse pathology in Prostate Cancer.
Presented at AUA, 2016.
January 20, 2016:
Abstract: A Live Cell Microfluidics Device Utilizing Phenotypic Biomarkers for Prostate Cancer.
Presented at IPCU, 2016.
January 7, 2016:
Abstract: A Live Cell Microfluidics Device Utilizing Phenotypic Biomarkers for Prostate Cancer.
Presented at ASCO-GU, 2016.
October 30, 2015:
Abstract: A novel live cell microfluidic diagnostic using phenotypic biomarkers with objective algorithmic analysis for
genitourinary cancer risk stratification.
BJUI Abstract presented at CURA Conference, 2015.
May 15, 2015:
Abstract: A Novel Live Cell Microfluidic Diagnostic Using Phenotypic Biomarkers With Objective Algorithmic Analysis for Prostate Cancer Risk Stratification.
Presented at AUA, 2015.
April 22, 2015:
Abstract: A Novel Live Cell Diagnostic Platform Measuring Phenotypic Biomarkers Using Objective Algorithmic Analysis Enables Further Risk Stratification For Intermediate-Risk Prostate Cancer Patients.
Presented at AACR, 2015.
February 24, 2015:
Novel Live Tumor Cell Diagnostic Test Utilizing Biophysical and Molecular Biomarkers to Assess Local, Advanced, and Metastatic Prostate Cancer
Presented at ASCO Genitourinary Cancers Symposium, 2015.